Avexima Diol LLC
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to Enoxaparin (NCT07124819) | Avexima Diol LLC | 2024-07-22 |
| Dimolegin® (60 mg) for Patients With Moderate COVID-19: A Non-Interventional Study (NCT07134738) | Avexima Diol LLC | 2024-06-07 |
Track Avexima Diol LLC automatically
Every clearance here is in the API, with alerts when new ones post.